Topics

Phil Erlanger Research Co., Inc. Company Profile

02:44 EST 21st November 2019 | BioPortfolio

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data, enabling Phil Erlanger Research to offer independent, value-added data and analysis on over 6000 equity issues, 139 industry groups and 18 sectors. Following his experience as Advest 's Chief Technical Analyst, and his 5 year tenure as Senior Technical Analyst for Fidelity Management & Research Co. , Inc., Philip B. Erlanger formed his own company with the goal of providing high quality, unique information and research.

Location

Maynard
Massachusetts
United States of America


News Articles [136 Associated News Articles listed on BioPortfolio]

Phil Sharp, CRISPR’ing the Heart & the Duchenne Data Gap on Oct. 17

Phil Sharp is one of the godfathers of biotech. He’s an MIT biologist, Nobel laureate and, as a Biogen (NASDAQ: BIIB) co-founder, one of the people responsible for turning Kendall Square into th...

Catch Duchenne Patient Power, Phil Sharp & More Next Week at The Broad

How did Phil Sharp, a kid from a small farm in Kentucky, become a Nobel prize winner and one of the godfathers of the biotech industry? How did Christine McSherry turn her youngest son’s devastating...

FA furious after US officials are caught in England’s World Cup hotel – The Guardian

FA furious after US officials are caught in England's World Cup hotel The GuardianWomen's World Cup: England boss Phil Neville says semi-final defeat would be failure BBC SportU.S. star Rapinoe wrec...

Organic Farming Guru Phil Coturri To address Sonoma Valley Cannabis Enthusiasts

Sonoma, CA - July 2, 2019 (Investorideas.com Newswire) Back to its regular Tuesday afternoon schedule, the Sonoma Valley Cannabis Enthusiasts welcomes esteemed organic farmer Phil Coturri as its featu...

England U21 vs France: Choudhury concedes pen and sent off – Leicestershire Live

England U21 vs France: Choudhury concedes pen and sent off Leicestershire LiveEngland 1-2 France: Own goal hands Three Lions nightmare start to European Championship ExpressEngland vs France, U21 Eu...

BioLineRx Ltd. (BLRX) CEO Phil Serlin on Q4 2018 Results - Earnings Call Transcript

BioLineRx Ltd. (BLRX) CEO Phil Serlin on Q3 2019 Results - Earnings Call Transcript

BioLineRx Ltd. (BLRX) CEO Phil Serlin on Q1 2019 Results - Earnings Call Transcript

PubMed Articles [614 Associated PubMed Articles listed on BioPortfolio]

In memoriam: Virendra Bhushan Mahesh, Ph.D., D.Phil. April 25, 1932 - July 16, 2019.

The lab management practices of "Research Exemplars" that foster research rigor and regulatory compliance: A qualitative study of successful principal investigators.

Conducting rigorous scientific inquiry within the bounds of research regulation and acceptable practice requires a principal investigator to lead and manage research processes and personnel. This stud...

Agent-based Modeling: A Research Strategy for Challenging Problems in Nursing Research.

For all our successes, many urgent health problems persist, and while some of these problems may be explored with established research methods, others remain uniquely challenging to investigate-maybe ...

Methodological research: open questions, the need for 'research on research' and its implications for evidence-based health care and reducing research waste.

A Dedicated Quarterly Research Meeting Increases Resident Research Productivity.

Research is a vital component of a plastic surgery residency. Residents participating in research are better able to critically evaluate literature, allowing them to stay current throughout their care...

Clinical Trials [1332 Associated Clinical Trials listed on BioPortfolio]

PHIL® Embolic System Pediatric IDE

The purpose of this study is to collect information about how the PHIL® Embolic System works in the treatment of intracranial dural arteriovenous fistulas. Data collected in this study wi...

PHIL in the Treatment of Intracranial dAVF.

This study is a prospective, multicenter, single-arm study. Patients with Dural Arteriovenous Fistulas (dAVF) have a few choice for safe treatment. In this study, all patients with qualify...

PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation (cAVM)

The primary objective of this study is to assess the efficacy and safety of PHIL® liquid embolic agent in endovascular embolization of cerebral arteriovenous malformations.

PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF

The primary objective of this study is to demonstrate the safety and efficacy of the PHIL® liquid in endovascular treatment of dural arteriovenous fistula.

Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the cells of the body. Because the genes are damaged, the body is unable to produce a group of protei...

Companies [1117 Associated Companies listed on BioPortfolio]

Phil Erlanger Research Co., Inc.

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data,...

Purple Heart Injury Laboratories

PHIL is a Defense Medicine™ incubator that supports the development of new technologies and therapies for healing battlefield injuries. PHIL’s objective is to become the...

Phil Inc.

Phil is an end-to-end prescription management service providing a convenient alternative to traditional pharmaceutical management. Through its desktop website and mobile app, Phil...

Phil Ellis Associates, Inc.

Phil Ellis Associates, Inc. is a professional search and recruiting firm specializing in the pharmaceutical, medical device, diagnostic, biomedical and allied industries and operates under the guidanc...

ValueMedics Research, LLC

Jonothan C. Tierce, C.Phil., and Elisabeth H. Hazard, Ph.D., formed ValueMedics in 2003. The initial staff was made up of the Health Economics, Outcomes Research, Pricing and Market Access unit of the...

More Information about "Phil Erlanger Research Co., Inc." on BioPortfolio

We have published hundreds of Phil Erlanger Research Co., Inc. news stories on BioPortfolio along with dozens of Phil Erlanger Research Co., Inc. Clinical Trials and PubMed Articles about Phil Erlanger Research Co., Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phil Erlanger Research Co., Inc. Companies in our database. You can also find out about relevant Phil Erlanger Research Co., Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record